Objectives: To investigate the predictive factors for transient urinary incontinence after transurethral enucleation with bipolar. Methods: We retrospectively analyzed the data of 584 patients who underwent transurethral enucleation with bipolar between December 2011 and September 2016 operated by a single surgeon. Urinary incontinence after transurethral enucleation with bipolar was defined as involuntary leakage of urine that required the use of pads. It was evaluated at 1 week, and 1, 3, 6, 12 and 24 months after transurethral enucleation with bipolar. We defined transient urinary incontinence as urinary incontinence persisting up to 1 month after transurethral enucleation with bipolar. Based on independent risk factors identified by a multivariate stepwise logistic regression analysis, a nomogram to predict transient urinary incontinence was developed. Results: Of the 584 patients, 17.3%, 13.5%, 3.1%, 0.41%, and 0% patients had urinary incontinence at 1 week, 1, 3, 6 and 12 months after transurethral enucleation with bipolar, respectively. The mean (AEstandard error) age was 69.6 AE 0.26 years, estimated prostate volume was 54.7 AE 0.91 cm 3 , operative time was 58.0 AE 1.1 min and the prostate specimen weight was 30.6 AE 0.69 g. On univariate analysis, age, prostate volume estimated by transrectal ultrasonography, prostate-specific antigen, prostate specimen weight, operative time, prostate specimen weight/prostate volume and prostate specimen weight/operative time were significant predictive factors for transient urinary incontinence after transurethral enucleation with bipolar. On multivariate analysis, age (hazard ratio 1.07, P-value = 0.0034) and prostate volume (hazard ratio 1.03, P-value < 0.0001) were independent risk factors for transient urinary incontinence after transurethral enucleation with bipolar. Conclusions: Age and prostate volume estimated by transrectal ultrasonography seem to represent significant independent risk factors for transient urinary incontinence after transurethral enucleation with bipolar. This should be well discussed with the patient before surgery.
Introduction
TUI can occur after any surgical treatment for BPH, including conventional TURP, 1,2 prostate enucleation such as HoLEP and TUEB. 5, 6 TUI has been recognized as one of the most distressing postoperative complications for both clinicians and patients. [7] [8] [9] [10] TUI after surgery for benign disease (e.g. endoscopic surgery for BPH) makes it a more sensitive problem than it is after surgery for malignant disease (e.g. radical prostatectomy), as these endoscopic surgeries mainly focus on the patient's QOL before and after surgery. It appears that the rate of TUI after enucleation endoscopic surgery for BPH is somewhat higher than that after traditional TURP. 9 Montorsi et al. showed that TUI was more common after HoLEP (44% at 1 month after surgery) than TURP (38.6% at 1 month after surgery), leading to a lower preference among clinicians in adopting the enucleation techniques, such as HoLEP and TUEB. 9 Cho et al. reported that the rate of TUI at 1 month after HoLEP was 15.1%, and its rate improved to 5.0% at 6 months after HoLEP. 3 Although TUI after endoscopic surgery for BPH can spontaneously improve within a few months, it remains a major complication, causing a negative impact on the patient's QOL. However, there has been no study to investigate the risk factors for TUI after TUEB. Thus, this is the first study aimed at evaluating the risk factors for TUI after TUEB.
Methods

Study design and end-point
After obtaining the institutional ethics committee approval, we retrospectively analyzed the data of 584 consecutive patients who underwent TUEB for symptomatic BPH at the hands of a single surgeon (YK) between December 2011 and August 2016. TUEB using the characteristic loop was first developed and introduced by Ken Nakagawa and Olympus Corporation (Tokyo, Japan). TUEB is safe, effective and can be used as a procedure for patients with BPH. 5, 6, 11, 12 This novel enucleation technique is especially useful for urologists, in hospitals where no laser system is available. 5 Preoperative and perioperative evaluation included PSA, IPSS and QOL score, and uroflowmetry measurements, OT, PSW, PSW/PV and PSW/OT. Postoperative complications including UI were also recorded. All patients underwent TRUS preoperatively, to measure the estimated PV. All patients underwent day care surgery under lumbar anesthesia. All patients were evaluated for the occurrence of UI postoperatively at 1 week, as well as at 1, 3, 6, 12 and 24 months after surgery. UI was defined as involuntary leakage of urine including both stress and urge UI that required the use of pads, in accordance with the recommendations of the International Continence Society. In the present study, we defined TUI as any UI up to 1 month after TUEB, which resolved spontaneously by 12 months after TUEB.
The potential predictive factors for TUI after TUEB included clinical factors, such as patient's age, PV estimated by TRUS, serum PSA, IPSS, QOLs, OT, PSW, PSW/PV, PSW/OT, uroflowmetry findings and surgeon's experience. Surgeon's experience means the continuous variable from the first case to the 584th case of TUEB by a single surgeon.
Operative procedure and technique
TUEB represents endoscopic blunt enucleation of the prostate using the Olympus SurgMaster (Olympus Europa Holding GmbH, Hamburg, Germany) TURis system and the TUEB loop (Olympus Corporation). The TUEB loop consists of two parts including a spatula for blunt adenoma enucleation and the standard tungsten wire loop for hemostasis by the bipolar system.
All procedures were carried out by a single surgeon (YK). The author (Hirasawa et al.) has previously described the TUEB technical details. 5 Briefly, after cystoscope insertion, resection was made at the 12 o'clock position and then at the 6 o'clock position to make it a two-block adenoma in the case of bilobular hypertrophy. In the case of trilobular hypertrophy, resection was made at the 12 o'clock position, then at the 5 and 7 o'clock positions. Next, the mucosa at the apical adenoma was circumferentially incised up to the depth of the surgical capsule.
Both of the lateral lobes and middle lobe were dissected off the surgical capsule, in a retrograde fashion from the apex towards the bladder using the TUEB loop, with arrest of bleeding. Instead of releasing the lobes into the bladder, they were left attached at the bladder neck by a narrow mushroom-like pedicle. Fragmentation of the enucleated lobes hanging at the bladder neck was carried out by traditional electrocautery wire loop resection, whereas the devascularized lobes were still connected to the surgical capsule by a narrow pedicle. This is known as "the mushroom technique."
Statistical analysis
Statistical analyses comparing each outcome between patients with TUI and patients without TUI after surgery were carried out using the Student's t-test for continuous variables, and the v 2 -test for categorical variables. Independent risk factors for the prediction of TUI after TUEB were identified using a multivariate stepwise logistic regression analysis. We developed the nomogram to predict TUI after TUEB based on these independent preoperative risk factors by using R for Windows (R Foundation for Statistical Computing, Vienna, Austria; http://www.r-project.org/). The predicted probability of TUI after TUEB was estimated in accordance with the results of a multivariate stepwise logistic regression analysis. Model coefficients were selected to optimize the ability of the model to predict the probability of TUI after TUEB. Calibration plots were used to graphically evaluate the association between the predicted probabilities of TUI after TUEB and the observed proportions. All analyses including the development of nomogram were carried out using R for Windows, version 3.1.0. For all statistical comparisons, differences with P < 0.05 were considered significant.
Results
Patients' characteristics in the present study are listed in Table 1 . Mean (AEstandard error) age was 69.6 AE 0.26 years. Mean prostate volume estimated by TRUS was 54.7 AE 0.91 cc, mean operative time was 58.0 AE 1.1 min and the mean specimen weight was 30.6 AE 0.69 g.
Rate of UI (≥1 pad) was 13.5% at 1 month after TUEB, but the rate dramatically decreased to 3%, 0.41%, 0%, and 0% at 3, 6, 12 and 24 months after TUEB, respectively (Table 2) . Therefore, almost all UI spontaneously resolved within 3-6 months in the present study. No patients experienced UI at 12-and 24-month follow up. Therefore, there were no patients with permanent UI after TUEB in the present study.
Differences between patients with TUI and those without TUI are summarized in Table 1 . As shown in Table 1 , patients in the TUI group were significantly older than patients in the group without TUI. PV of patients in the TUI group was also significantly higher than that of patients in the group without TUI. Furthermore, PSA, OT, PSW, PSW/ PV and PSW/OT were significantly higher in patients in the TUI group than in patients without TUI.
On univariate analysis, age (HR 1.06, P-value = 0.0049), PV estimated by TRUS (HR 1.02, P-value < 0.0001), PSA (HR 1.13, P = 0.0011), PSW (HR 1.03, P-value < 0.0001), OT (HR 1.02, P-value < 0.0001), PSW/PV (HR 1.03, Pvalue = 0.0021) and PSW/OT (HR 4.3, P-value = 0.026) were significant predictive factors for TUI after TUEB; however, IPSS, QOL, Q max , history of preoperative urinary retention and surgeon's experience were not significant (Table 3) .
On multivariate analysis, age (HR 1.07, P-value = 0.0034) and PV (HR 1.03, P-value < 0.0001) were independent risk factors for TUI after TUEB (Table 3) . Based on these results, we developed a nomogram that graphically shows the multivariate impact of each variable (Fig. 1) . The concordance index of this model was 0.690. Calibration plots are shown in Figure 2 . The differences between the observed and predicted probabilities were within 2% for 90% of the patients (Fig. 2) .
Discussion
Endoscopic enucleation of the prostatic adenomas is increasing as a novel surgical treatment for BPH. However, TUI after the procedure is the main adverse event. The aim of surgical treatment for BPH is to remove the prostatic adenoma, thereby improving the uroflowmetry results, patients' symptoms and QOL. TUI after surgery for BPH might restrict patients' activity of daily living and impair QOL. 13, 14 TUI after endoscopic enucleation of the prostate occurred in 13.5% of patients at 1 month after TUEB in the present study and in 7.1-44% after HoLEP in previous studies. 9, 15, 16 Therefore, it is important to determine clinical incidence and risk factors of TUI after surgical treatment for BPH. However, there has been no study to investigate its risk factors after TUEB.
Thus, this is the first study to evaluate risk factors of TUI after TUEB.
In the present study, age and prostate volume were independent risk factors for TUI at 1 month after TUEB. Postoperatively, the capacity of prostatic fossa can increase with increasing PV, after complete removal of the adenoma by an enucleation surgical procedure of the prostate. This causes urine trapping and leakage with stress maneuvers in the short-term, although prostatic specimen weight was not a significant risk factor for TUI in the present study. This could be because of its significant correlation with prostate volume on multivariate analysis. In their review article, Walz et al. mentioned an inner muscle layer of the urethral sphincter that surrounds the urethra, and consists of smooth muscle fibers and elastic tissue. 17 The retrograde dissection of the apex of the prostate in the TUEB might stretch the inner longitudinal layer around the apical gland. This could result in transient damage of the urethral sphincter, leading to TUI. Operative time for enucleating the adenoma increases with increasing prostate volume, and it causes stretching of the inner longitudinal layer around the apical gland for a longer time. This could be the reason why patients with larger prostates experienced more TUI after TUEB. In contrast, open prostatectomy does not stretch this inner layer of the sphincter because of antegrade dissection from the bladder neck to the apex, resulting in a lower incidence of TUI. In fact, the incidence of TUI after open prostatectomy reported by previous studies was lower at 5.6-9.4%. 18, 19 The overall occurrence of TUI after TUEB in the present study was higher than that after open prostatectomy.
Shigemura et al. showed that patient age and prostate volume were significant predictive factors for TUI at 1 month after HoLEP. 20 Additionally, Nam et al. also showed that advanced age and longer operative time were significant risk factors for TUI after HoLEP. 4 They suggested that the sphincter tissue is more fragile and sparse in the elderly, compared with young men, leading to an increased susceptibility to damage while forcing the tissue when enucleating the adenoma. 4 The results of these two studies seem to be similar to the present results. However, operative time was not a significant risk factor for TUI on multivariate analysis in our study. This could be because of its significant correlation with prostate volume, as seen on multivariate analysis.
TUI is one of the most distressing postoperative complications of TUEB or HoLEP for patients with BPH. 13, 14 In the present study, although TUI occurred in 17.3% of all patients after TUEB, 82.2%, of them showed spontaneous recovery within 3 months. Involuntary leakage of urine leading to a hygienic and social inconvenience can cause significant impairment of activity of daily living or QOL of patients for several months after enucleation surgery. The complaints of UI can be very stressful to both clinicians and patients. Hence, this common adverse event should be well discussed with the patients before surgery; more so, because there are other alternatives for treatment of BPH, such as medication to reduce PV. However, there has been no preoperative nomogram to predict TUI after TUEB or HoLEP. We developed a nomogram based on two preoperative risk factors to predict TUI after TUEB. This predictive nomogram might be useful to help patients make a decision about their choice of treatment for BPH. There were several limitations to the present study. The major limitation of the present study was its retrospective design. As a result, a systematic follow up with urodynamic assessment or erectile function data could not be recorded, which would have been interesting to investigate. Second, we documented UI based on pad usage, and did not assess the type of UI, such as stress or urgency or mixed UI. However, the diagnosis of stress/urgency/mixed urinary incontinence depends on the patients' subjective complaint according to the recommendations of the International Continence Society, and there are no standard criteria for reporting urinary incontinence. Unfortunately, the present data also lack patient' subjective complaint, and there were only objective data on pad use, which proved whether patients encountered UI after surgery or not. Additionally, the present data lack some important patients' characteristics, such as body mass index or medical history (e.g. diabetes or brain infarction), or details of IPSS or intravesical prostatic protrusion. As a result, we did not investigate the correlation between body mass index or medical history, or details of IPSS or intravesical prostatic protrusion and TUI. These factors have possibilities to affect TUI after surgery. Therefore, we should investigate the correlation between these factors and TUI in the future. In addition, in this single surgeon's series, the surgeon's experience was not a significant risk factor for TUI after TUEB. However, the surgeon's experience might become a risk factor for TUI like other complications in other surgeon's series. Therefore, we should investigate whether surgeon's experience become a risk factor for TUI after TUEB in multisurgeon series in the future. Finally, although we validated our prediction nomogram and the C-index (0.690) was not bad, it has not been validated in an independent cohort. Therefore, to confirm whether our prediction nomogram is correctly useful in the real clinical practice, we require external validation in another institution in the future.
In conclusion, we found that age and PV estimated by TRUS were significant independent risk factors for TUI at 1 month after TUEB. It should be well discussed with the patient before surgery.
